AAgMarker 1.0: a resource of serological autoantigen biomarkers for clinical diagnosis and prognosis of various human diseases

Abstract Autoantibodies are produced to target an individual's own antigens (e.g. proteins). They can trigger autoimmune responses and inflammation, and thus, cause many types of diseases. Many high-throughput autoantibody profiling projects have been reported for unbiased identification of serological autoantigen-based biomarkers. However, a lack of centralized data portal for these published assays has been a major obstacle to further data mining and cross-evaluate the quality of these datasets generated from different diseases. Here, we introduce a user-friendly database, AAgMarker 1.0, which collects many published raw datasets obtained from serum profiling assays on the proteome microarrays, and provides a toolbox for mining these data. The current version of AAgMarker 1.0 contains 854 serum samples, involving 136 092 proteins. A total of 7803 (4470 non-redundant) candidate autoantigen biomarkers were identified and collected for 12 diseases, such as Alzheimer's disease, Bechet's disease and Parkinson's disease. Seven statistical parameters are introduced to quantitatively assess these biomarkers. Users can retrieve, analyse and compare the datasets through basic search, advanced search and browse. These biomarkers are also downloadable by disease terms. The AAgMarker 1.0 is now freely accessible at http://bioinfo.wilmer.jhu.edu/AAgMarker/. We believe this database will be a valuable resource for the community of both biomedical and clinical research.

[1]  Robert G. Nagele,et al.  Natural IgG Autoantibodies Are Abundant and Ubiquitous in Human Sera, and Their Number Is Influenced By Age, Gender, and Disease , 2013, PloS one.

[2]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[3]  Meena Subramanyam,et al.  Translational biomarkers: from discovery and development to clinical practice. , 2016, Drug discovery today. Technologies.

[4]  Andrew J. G. Simpson,et al.  CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens , 2008, Nucleic Acids Res..

[5]  J. Qian,et al.  DNA methylation presents distinct binding sites for human transcription factors , 2013, eLife.

[6]  Nan Wang,et al.  PMD: A Resource for Archiving and Analyzing Protein Microarray data , 2016, Scientific reports.

[7]  Göran Hallmans,et al.  Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis , 2011, Arthritis research & therapy.

[8]  R. Nagele,et al.  Diagnosis of Alzheimer's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera , 2011, PloS one.

[9]  Dan Wang,et al.  AAgAtlas 1.0: a human autoantigen database , 2016, Nucleic Acids Res..

[10]  R Hal Scofield,et al.  Autoantibodies in Rheumatoid Arthritis Autoantibodies in Pregnancy Autoantibodies as Predictors of Disease , 2022 .

[11]  Heng Zhu,et al.  Identification of Novel Biomarkers for Behcet Disease Diagnosis Using Human Proteome Microarray Approach* , 2016, Molecular & Cellular Proteomics.

[12]  I. Xenarios,et al.  UniProtKB/Swiss-Prot, the Manually Annotated Section of the UniProt KnowledgeBase: How to Use the Entry View. , 2016, Methods in molecular biology.

[13]  P H Plotz,et al.  The role of autoantibodies in autoimmune disease. , 1993, Annual review of immunology.

[14]  J. Jett,et al.  udit of the autoantibody test , EarlyCDT ®-Lung , in 1600 patients : n evaluation of its performance in routine clinical practice , 2014 .

[15]  Umashanger Thayasivam,et al.  Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease. , 2015, Immunology letters.

[16]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[17]  George I. Mias,et al.  Specific Plasma Autoantibody Reactivity in Myelodysplastic Syndromes , 2013, Scientific Reports.

[18]  Yu Zhang,et al.  HPtaa database-potential target genes for clinical diagnosis and immunotherapy of human carcinoma , 2005, Nucleic Acids Res..

[19]  Paolo Casali,et al.  Nature and functions of autoantibodies , 2008, Nature Clinical Practice Rheumatology.

[20]  P. Lipsky,et al.  Autoantibodies as predictors of disease. , 2001, The Journal of clinical investigation.

[21]  Tatiana A. Tatusova,et al.  Gene: a gene-centered information resource at NCBI , 2014, Nucleic Acids Res..

[22]  Sung Hee Choi,et al.  Identification of Novel Autoantibodies in Type 1 Diabetic Patients Using a High-Density Protein Microarray , 2014, Diabetes.

[23]  Robert Petryszak,et al.  ArrayExpress update—simplifying data submissions , 2014, Nucleic Acids Res..

[24]  Li Wang,et al.  Identification of New Autoantigens for Primary Biliary Cirrhosis Using Human Proteome Microarrays* , 2012, Molecular & Cellular Proteomics.

[25]  Ying Zhang,et al.  The neXtProt knowledgebase on human proteins: current status , 2014, Nucleic Acids Res..

[26]  Joshua LaBaer,et al.  Plasma Autoantibodies Associated with Basal-like Breast Cancers , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[27]  R. Nagele,et al.  Diagnosis of Parkinson's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera , 2011, PloS one.

[28]  Li Li,et al.  Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and “antibodyome” measures , 2009, Proceedings of the National Academy of Sciences.

[29]  Aliasgar Moiyadi,et al.  Evaluation of autoantibody signatures in meningioma patients using human proteome arrays , 2017, Oncotarget.